We have located links that may give you full text access.
IFN- promoter polymorphisms do not affect QuantiFERON TB Gold In-Tube test results in a Canadian population.
International Journal of Tuberculosis and Lung Disease 2016 December
BACKGROUND: Several studies have shown polymorphisms within the interferon-gamma (IFN-) promoter influence cytokine expression. The interferon-gamma release assay (IGRA) relies on the ability to produce IFN- in response to tuberculosis (TB) specific antigens. This study determined the relationship between the IFN- +874 A/T promoter polymorphism and the performance of the QuantiFERON-TB Gold In-Tube (QFT-GIT) test in an ethnically diverse Canadian population.
METHODS: A total of 190 participants were categorised into three groups based on history of and exposure to TB: active TB (n = 55), TB exposed (n = 55) and presumably TB unexposed controls (n = 80). All participants underwent QFT-GIT testing, and DNA was extracted from whole blood and probed for polymorphism at position +874 (T/A) of intron 1 of IFN-. Statistical relationships between the QFT-GIT results, polymorphisms and demographic data were evaluated.
RESULTS: IFN- +874 genotype frequencies among the entire study population (n = 190) were A/A (45.8%), T/A (39.5%), and T/T (14.7%). Among the three study groups, there was no correlation between QFT-GIT results and the IFN- +874 A/T genotype, and no correlation of genotype with IFN- production in response to either Mycobacterium tuberculosis antigens or mitogenic stimulation.
CONCLUSION: Our results indicate that the IFN- +874 promoter polymorphism does not influence QFT-GIT performance in this study population.
METHODS: A total of 190 participants were categorised into three groups based on history of and exposure to TB: active TB (n = 55), TB exposed (n = 55) and presumably TB unexposed controls (n = 80). All participants underwent QFT-GIT testing, and DNA was extracted from whole blood and probed for polymorphism at position +874 (T/A) of intron 1 of IFN-. Statistical relationships between the QFT-GIT results, polymorphisms and demographic data were evaluated.
RESULTS: IFN- +874 genotype frequencies among the entire study population (n = 190) were A/A (45.8%), T/A (39.5%), and T/T (14.7%). Among the three study groups, there was no correlation between QFT-GIT results and the IFN- +874 A/T genotype, and no correlation of genotype with IFN- production in response to either Mycobacterium tuberculosis antigens or mitogenic stimulation.
CONCLUSION: Our results indicate that the IFN- +874 promoter polymorphism does not influence QFT-GIT performance in this study population.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app